Ultomiris demonstrated statistically significant and clinically meaningful reduction of proteinuria in adults with IgAN in I CAN phase III trial: Cambridge, UK Wednesday, April 22 ...

Ultomiris has met its primary endpoint in a phase III trial targeting immunoglobulin A nephropathy (IgAN), a rare ...

Positive high-level results from a prespecified interim analysis of the I CAN Phase III trial showed that Ultomiris (ravulizumab) met its primary ...

Vera Clinic, internationally recognised as a leading centre of innovation in hair restoration surgery, has released the full ...

Certainly, cravings can get the best of us and in some cases too much of what we crave can result in some unhealthy outcomes.

NAB believes that with GPS increasingly recognized as a potential single point of failure, BPS has an important role to play.

This is the green revolution that nobody talks about at climate summits. While world leaders debate carbon credits and industrial emissions, a quieter transformation is unfolding in kitchens, utility ...

ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease ...

As enterprises race to deploy autonomous AI agents, a growing concern has emerged around what these agents are permitted to ...

Nigeria is paying a measurable price for its security crisis — in soldiers’ lives, in lost investment, in farming communities ...

Certified trainer Chris Freytag has spent more than 35 years in the fitness industry, coaching women through the physical ...

Employing in the region of 500 people, ArraTipp is an Agri dairy-based organisation formed in March 2025, from the merger of ...